150 related articles for article (PubMed ID: 2002346)
1. Responsiveness of striatal dopamine release in awake animals after chronic 1-methyl-4-phenylpyridinium ion-induced lesions of the substantia nigra.
Santiago M; Westerink BH; Rollema H
J Neurochem; 1991 Apr; 56(4):1336-42. PubMed ID: 2002346
[TBL] [Abstract][Full Text] [Related]
2. Nigral and striatal comparative study of the neurotoxic action of 1-methyl-4-phenylpyridinium ion: involvement of dopamine uptake system.
Santiago M; Machado A; Cano J
J Neurochem; 1996 Mar; 66(3):1182-90. PubMed ID: 8769882
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of intranigral application of MPP+ on nigral and bilateral striatal release of dopamine simultaneously recorded by microdialysis.
Santiago M; Rollema H; de Vries JB; Westerink BH
Brain Res; 1991 Jan; 538(2):226-30. PubMed ID: 1707325
[TBL] [Abstract][Full Text] [Related]
4. Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats.
Santiago M; Westerink BH
J Neurochem; 1991 Sep; 57(3):738-47. PubMed ID: 1677674
[TBL] [Abstract][Full Text] [Related]
5. Complex I inhibitor effect on the nigral and striatal release of dopamine in the presence and absence of nomifensine.
Santiago M; Granero L; Machado A; Cano J
Eur J Pharmacol; 1995 Jul; 280(3):251-6. PubMed ID: 8566093
[TBL] [Abstract][Full Text] [Related]
6. Chronic effects of single intrastriatal injections of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium studied by microdialysis in freely moving rats.
Espino A; Cutillas B; Tortosa A; Ferrer I; Bartrons R; Ambrosio S
Brain Res; 1995 Oct; 695(2):151-7. PubMed ID: 8556325
[TBL] [Abstract][Full Text] [Related]
7. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion.
Sirinathsinghji DJ; Heavens RP; Richards SJ; Beresford IJ; Hall MD
Neuroscience; 1988 Oct; 27(1):117-28. PubMed ID: 3264391
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous recording of the release of nigral and striatal dopamine in the awake rat.
Santiago M; Westerink BH
Neurochem Int; 1992 Mar; 20 Suppl():107S-110S. PubMed ID: 1365406
[TBL] [Abstract][Full Text] [Related]
9. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats.
Robertson GS; Damsma G; Fibiger HC
J Neurosci; 1991 Jul; 11(7):2209-16. PubMed ID: 1712381
[TBL] [Abstract][Full Text] [Related]
10. Estrogen reduces acute striatal dopamine responses in vivo to the neurotoxin MPP+ in female, but not male rats.
Disshon KA; Dluzen DE
Brain Res; 2000 Jun; 868(1):95-104. PubMed ID: 10841892
[TBL] [Abstract][Full Text] [Related]
11. Effects of age and dopamine agonists and antagonists on striatal dopamine release in the rat: an in vivo microdialysis study.
Santiago M; Machado A; Cano J
Mech Ageing Dev; 1993 Apr; 67(3):261-7. PubMed ID: 7686993
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of intracerebrally administered MPP+ (1-methyl-4-phenylpyridinium) in three species: microdialysis of dopamine and metabolites in mouse, rat and monkey striatum.
Rollema H; Alexander GM; Grothusen JR; Matos FF; Castagnoli N
Neurosci Lett; 1989 Dec; 106(3):275-81. PubMed ID: 2601882
[TBL] [Abstract][Full Text] [Related]
13. Increased proenkephalin mRNA levels in the rat neostriatum following lesion of the ipsilateral nigrostriatal dopamine pathway with 1-methyl-4-phenylpyridinium ion (MPP+): reversal by embryonic nigral dopamine grafts.
Sirinathsinghji DJ; Dunnett SB
Brain Res Mol Brain Res; 1991 Feb; 9(3):263-9. PubMed ID: 1851529
[TBL] [Abstract][Full Text] [Related]
14. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--III. Reversal by embryonic nigral dopamine grafts.
Sirinathsinghji DJ; Dunnett SB; Northrop AJ; Morris BJ
Neuroscience; 1990; 37(3):757-66. PubMed ID: 2247221
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion.
Espino A; Llorens J; Calopa M; Bartrons R; Rodriguez-Farré E; Ambrosio S
Brain Res; 1995 Jan; 669(1):19-25. PubMed ID: 7712161
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival of intrastriatal dopaminergic grafts: modulation of acetylcholine release by graft-derived dopamine.
Jackisch R; Duschek M; Neufang B; Rensing H; Hertting G; Herman JP
J Neurochem; 1991 Jul; 57(1):267-76. PubMed ID: 2051168
[TBL] [Abstract][Full Text] [Related]
17. Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis.
Strecker RE; Sharp T; Brundin P; Zetterström T; Ungerstedt U; Björklund A
Neuroscience; 1987 Jul; 22(1):169-78. PubMed ID: 2819773
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of dopamine release by N-methyl-D-aspartate receptors in rat striatum after partial and extreme lesions of the nigro-striatal pathway.
Andrés ME; Gysling K; Bustos G
Brain Res; 1998 Jun; 797(2):255-66. PubMed ID: 9666143
[TBL] [Abstract][Full Text] [Related]
19. Disappearance of the mu-opiate receptor patches in the rat neostriatum following lesioning of the ipsilateral nigrostriatal dopamine pathway with 1-methyl-4-phenylpyridinium ion (MPP+): restoration by embryonic nigral dopamine grafts.
Sirinathsinghji DJ; Dunnett SB
Brain Res; 1989 Dec; 504(1):115-20. PubMed ID: 2557122
[TBL] [Abstract][Full Text] [Related]
20. Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.
Yang J; Hu LF; Liu X; Zhou F; Ding JH; Hu G
Life Sci; 2006 Mar; 78(17):1940-4. PubMed ID: 16216278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
